Evidence map›Paper›PMID 41003304›Full record

ReviewMarine drugs2025

Postbiotics of Marine Origin and Their Therapeutic Application.

Isabel M Cerezo, Olivia Pérez-Gómez, Sonia Rohra-Benítez, Marta Domínguez-Maqueda, Jorge García-Márquez, Salvador Arijo

Abstract readReview
In one paragraph

Review in Marine drugs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Beyond Probiotics: Postbiotics for Healthy Aquaculture.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Isabel M CerezoDepartamento de Microbiología, Facultad de Ciencias, Instituto Andaluz de Biotecnología y Desarrollo Azul (IBYDA), CEIMAR, Universidad de Málaga, Campus Universitario de Teatinos s/n, 29071 Málaga, Spain.ORCID 0000-0002-9265-3732
Olivia Pérez-GómezDepartamento de Microbiología, Facultad de Ciencias, Instituto Andaluz de Biotecnología y Desarrollo Azul (IBYDA), CEIMAR, Universidad de Málaga, Campus Universitario de Teatinos s/n, 29071 Málaga, Spain.ORCID 0000-0002-6305-7501
Sonia Rohra-BenítezDepartamento de Microbiología, Facultad de Ciencias, Instituto Andaluz de Biotecnología y Desarrollo Azul (IBYDA), CEIMAR, Universidad de Málaga, Campus Universitario de Teatinos s/n, 29071 Málaga, Spain.ORCID 0009-0005-4782-8416
Marta Domínguez-MaquedaDepartamento de Microbiología, Facultad de Ciencias, Instituto Andaluz de Biotecnología y Desarrollo Azul (IBYDA), CEIMAR, Universidad de Málaga, Campus Universitario de Teatinos s/n, 29071 Málaga, Spain.ORCID 0000-0001-5605-7071
Jorge García-MárquezDepartamento de Microbiología, Facultad de Ciencias, Instituto Andaluz de Biotecnología y Desarrollo Azul (IBYDA), CEIMAR, Universidad de Málaga, Campus Universitario de Teatinos s/n, 29071 Málaga, Spain.ORCID 0000-0001-8175-0409
Salvador ArijoDepartamento de Microbiología, Facultad de Ciencias, Instituto Andaluz de Biotecnología y Desarrollo Azul (IBYDA), CEIMAR, Universidad de Málaga, Campus Universitario de Teatinos s/n, 29071 Málaga, Spain.ORCID 0000-0001-6873-1908

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increase in antibiotic-resistant pathogens has prompted the search for alternative therapies. One such alternative is the use of probiotic microorganisms. However, growing interest is now turning toward postbiotics-non-viable microbial cells and/or their components or metabolites-that can confer health benefits without the risks associated with administering live microbes. Marine ecosystems, characterized by extreme and diverse environmental conditions, are a promising yet underexplored source of microorganisms capable of producing unique postbiotic compounds. These include bioactive peptides, polysaccharides, lipoteichoic acids, and short-chain fatty acids produced by marine bacteria. Such compounds often exhibit enhanced stability and potent biological activity, offering therapeutic potential across a wide range of applications. This review explores the current knowledge on postbiotics of marine origin, highlighting their antimicrobial, anti-inflammatory, immunomodulatory, and anticancer properties. We also examine recent in vitro and in vivo studies that demonstrate their efficacy in human and animal health. Some marine bacteria that have been studied for use as postbiotics belong to the genera

Indexed as

Aquatic OrganismsBacteriaProbioticsAnimalsAnti-Bacterial AgentsAnti-Infective AgentsAnti-Inflammatory AgentsAntineoplastic AgentsHumansImmunomodulating AgentsAnti-Bacterial AgentsAnti-Infective AgentsAnti-Inflammatory AgentsAntineoplastic AgentsImmunomodulating Agentsantimicrobial activitybacteriaextracellular productsimmunomodulationmicrobiotaprobiotic

Identifiers

PMID41003304
PMCPMC12471580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.